Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study

Current HIV Research
J RaninD Jevtovic

Abstract

The study aimed to correlate the status of hepatitis C (HCV) and hepatitis B virus (HBV) co-infection in patients with human immunodeficiency virus (HIV) infection with clinical and demographic data prior to starting highly active antiretroviral therapy (HAART) and assess the impact of HCV and HBV co-infection on the natural history of HIV infection. The study involved a total of 836 treatment-naive patients with available serological status for HBV and HCV at the point of therapy initiation. Patients were stratified into four groups: HIV mono-infection, HIV/HCV, HIV/HBV, and HIV/HCV/HBV co-infection. Demographic, epidemiological, immunological and clinical characteristics were analyzed in order to assess the possible impact of HCV and HBV co-infection on HIV - related immunodeficiency and progression to AIDS. The prevalence of HCV and HBV co-infection in our cohort was 25.7% and 6.3%, respectively. Triple HIV/HCV/HBV infection was recorded in 1.7% of the patients. In comparison with those co-infected with HCV, patients with HIV mono-infection had lower levels of serum liver enzymes activity and higher CD4 cell counts, and were less likely to have CD4 cell counts below100 cells/µL and clinical AIDS, with OR 0.556 and 0.561, res...Continue Reading

References

Nov 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T L WrightB F Scharschmidt
Jul 1, 1997·Journal of Hepatology·J OckengaR E Schmidt
Dec 17, 1998·European Journal of Gastroenterology & Hepatology·G H HaydonP C Hayes
Feb 15, 2001·The Journal of Infectious Diseases·E S DaarUNKNOWN Hemophilia Growth and Development Study
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Mark S SulkowskiDavid L Thomas
Oct 11, 2002·Archives of Internal Medicine·Andrea De LucaUNKNOWN Italian Cohort Naive Antiretrovirals Study Group
Jul 16, 2003·HIV Medicine·D LincolnUNKNOWN Australian HIV Observational Database
Apr 20, 2004·AIDS·Vincent SorianoJurgen Rockstroh
Dec 15, 2005·Journal of Hepatology·Miriam J Alter
Jan 16, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dj JevtovićO Djurković-Djaković
Sep 15, 2007·Journal of Medical Virology·Pietro FilippiniEvangelista Sagnelli
Sep 15, 2007·World Journal of Gastroenterology : WJG·Shanmugam SaravananSadras Panchatcharam Thyagarajan
Dec 20, 2007·AIDS·Mark S SulkowskiDavid L Thomas
Mar 8, 2008·Gastroenterology·Wenyu LinRaymond T Chung
Apr 10, 2008·Journal of Gastroenterology and Hepatology·Chi-Jen Chu, Shou-Dong Lee
May 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios K NikolopoulosAngelos Hatzakis
Aug 8, 2009·AIDS Care·Deborah L JonesMahendra Kumar
Oct 15, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Jonathan Leserman RobbinsAlex H Kral
Jan 12, 2011·Current HIV/AIDS Reports·Eva A Operskalski, Andrea Kovacs
Dec 8, 2011·The Journal of Infectious Diseases·Helen M ChunUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
May 11, 2012·The New England Journal of Medicine·Athena P KourtisDenise J Jamieson
Jul 13, 2012·Journal of Korean Medical Science·Jong Hun KimVictoria Sharp
Feb 15, 2013·The Journal of Infectious Diseases·Arthur Y KimDaniel R Church
Apr 5, 2013·Bulletin of the World Health Organization·Bradley M MathersMathew Hickman
Jun 26, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Marina SiljicMaja Stanojevic
Sep 11, 2013·BMC Research Notes·Beatrice Mukami MuriukiSamoel Ashimosi Khamadi
Feb 4, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Djordje JevtovićOlgica Djurković-Djaković
May 29, 2014·International Journal of Molecular Sciences·Claudio M MastroianniVincenzo Vullo

❮ Previous
Next ❯

Citations

May 5, 2020·Clinical and Experimental Immunology·H HouZ Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.